-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FMHr2A3v3QqP90H7XD0OmpwbvsrxHdulTA+tydcBj9+5bObmVqDDcenGOvmQgcjv 5csO9BhK7kR46N4Nq7mEsQ== 0001404219-09-000017.txt : 20090330 0001404219-09-000017.hdr.sgml : 20090330 20090330215142 ACCESSION NUMBER: 0001404219-09-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090326 FILED AS OF DATE: 20090330 DATE AS OF CHANGE: 20090330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EBERSMAN DAVID A CENTRAL INDEX KEY: 0001214123 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09813 FILM NUMBER: 09715803 MAIL ADDRESS: STREET 1: C/O GENENTECH INC STREET 2: 1 DNA WAY MS 49 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080-4990 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-225-1000 MAIL ADDRESS: STREET 1: 1 DNA WAY STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2009-03-26 1 0000318771 GENENTECH INC DNA 0001214123 EBERSMAN DAVID A 1 DNA WAY SO SAN FRANCISCO CA 94080 0 1 0 0 EVP & CHIEF FINANCIAL OFFICER Common Stock 2009-03-26 2009-03-26 4 D 0 3641 95 D 0 D Common Stock 2009-03-26 4 D 0 4977 95 D 0 I by Trust Non-Qualified Stock Option (right to buy) 14.28 2009-03-26 4 D 0 180000 0 D 2002-09-12 2012-09-12 Common Stock 180000 0 D Non-Qualified Stock Option (right to buy) 20.9 2009-03-26 4 D 0 106400 0 D 2001-09-26 2011-09-26 Common Stock 106400 0 D Non-Qualified Stock Option (right to buy) 42.05 2009-03-26 4 D 0 132000 0 D 2003-09-11 2013-09-11 Common Stock 132000 0 D Non-Qualified Stock Option (right to buy) 53.23 2009-03-26 4 D 0 150000 0 D 2004-09-23 2014-09-23 Common Stock 150000 0 D Non-Qualified Stock Option (right to buy) 79.17 2009-03-26 4 D 0 135000 0 D 2007-09-20 2016-09-20 Common Stock 135000 0 D Non-Qualified Stock Option (right to buy) 79.55 2009-03-26 4 D 0 125000 0 D 2008-09-20 2017-09-20 Common Stock 125000 0 D Non-Qualified Stock Option (right to buy) 85.83 2009-03-26 4 D 0 157500 0 D 2005-09-23 2015-09-23 Common Stock 157500 0 D Disposed of pursuant to the Agreement and Plan of Merger between the issuer, Roche Holdings Inc. and Roche Investments USA dated March 12, 2009. Shares held in the Ebersman Family Trust UAD 5/29/02, for which the reporting person is a co-trustee and beneficiary along with his spouse. At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration. At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration. At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration. By: ADAM B. LAUTNER For: DAVID A. EBERSMAN 2009-03-30 -----END PRIVACY-ENHANCED MESSAGE-----